Esco is committed to flatten the curve of the COVID-19 pandemic through its 'trace, test, and treat' platform which promotes worldwide eradication of the virus.
In its trace stage, Esco designed and created two COVID-19 booths: Mass Screening Swab Booth™ (MSSB™) and the infectious Desease Diagnostics Sampling Booth™ (IDDSB™) with the goal of diagnosing a number of asymptomatic and symptomatic Persons Under Investigation/Monitoring (PUI/PUM), respectively, in a short span of time while eliminating the risk of front-liners contracting the virus.
With the booth's programmed pressurization (MSSB™: +ve for HCW and -ve for PUI booth; and for IDDSB™: -ve), strict airflow regime partnered with stringent SOPs, Esco guarantees a safe and efficient mas diagnosing in each community to prevent further spread of the virus.
Esco provides turnkey mobile medical solutions to international community to help prevent further spread of infectious diseases such as Corona Virus. We ensure availability of stocks - as outbreaks have no breaks, and so do we!LEARN MORE
The TREAT Platform is the 3rd part of Esco Aster's end-to-end platform for the COVID-19 pandemic. The innovations under this division im to reduce healthcare-associated infections (HAIs) and to give turnkey solutions to increase both patient and hospital outcomes.
Surge of individuals requiring treatment from healthcare professionals has brought about space saturation as appropriate and suitable facilities have been compromised due to high demand. The exhausted healthcare setting not only incapacitates being able to cater to patient's needs but it also increases risk exposure of healthcare workers who provide quality care for their patients.
As a response, Esco designed modular isolation rooms utilizing the Esco Aster Airborne infection Isolation (AIIR) Technology to serve as an aid in relieving the pandemic-induced shortage in treatment spaces, as well as turnkey treatment centers to reduce public health system exhaustion.